VERO vs HIMS vs SKIN vs TDOC vs ELF

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -15. 1% for Venus Concept Inc. (VERO). e. l. f. Beauty, Inc. (ELF) offers the better valuation at 31. 7x trailing P/E (19. 6x forward), making it the more compelling value choice. Analysts rate e. l. f. Beauty, Inc. (ELF) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, e.

l. f. Beauty, Inc. (ELF) is the cheapest at 31. 7x versus Hims & Hers Health, Inc. at 55. 4x. On forward P/E, e. l. f. Beauty, Inc. is actually cheaper at 19. 6x.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +173. 9%, compared to -99. 9% for Venus Concept Inc. (VERO). Over 10 years, the gap is even starker: HIMS returned +188. 5% versus VERO's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Venus Concept Inc.

(VERO) is the lower-risk stock at 1. 39β versus Hims & Hers Health, Inc. 's 2. 48β — meaning HIMS is approximately 78% more volatile than VERO relative to the S&P 500. On balance sheet safety, e. l. f. Beauty, Inc. (ELF) carries a lower debt/equity ratio of 41% versus 15% for Venus Concept Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -15. 1% for Venus Concept Inc. (VERO). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -869. 0% for Venus Concept Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

e.

l. f. Beauty, Inc. (ELF) is the more profitable company, earning 8. 5% net margin versus -72. 5% for Venus Concept Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELF leads at 12. 0% versus -41. 9% for VERO. At the gross margin level — before operating expenses — ELF leads at 71. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, e.

l. f. Beauty, Inc. (ELF) trades at 19. 6x forward P/E versus 58. 3x for Hims & Hers Health, Inc. — 38. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SKIN: 124. 1% to $1. 30.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Venus Concept Inc.

(VERO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VERO: -100. 0%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (VERO (Healthcare) and HIMS (Healthcare) and SKIN (Consumer Defensive) and TDOC (Healthcare) and ELF (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VERO is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; SKIN is a small-cap quality compounder stock; TDOC is a small-cap quality compounder stock; ELF is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.